FUTURE RESEARCH IMPACT: Increasing Chiropractic Credibility
Dr. Erwin’s research will lead to a minimally invasive therapy to treat degenerative disc disease and contribute to the rehabilitation of patients living with degenerative disc disease.
Dr. Erwin’s team is investigating the next generation of cellular/molecular therapy for degenerative spinal disease. Their most exciting discovery to date has been the result of over 18 years of fundamental scientific work – the discovery of the essential molecules that are the building blocks of the disc. When injected into an injured disc, these essential molecules (‘the magic stuff’) stop degeneration and, in pre-clinical animal models, return injured discs to a near normal state.
“When one considers the experts in the field who are studying the molecular biology of the intervertebral disc, Dr. Mark Erwin’s name rapidly rises to the top of the list. Most certainly, the clinical implications of his research findings are soon to be realized. Dr. Erwin is to be congratulated for this ground breaking work.” – Dr. James T. Rutka, MD, PhD, FRCSC, FACS, FAAP, FAANS,RS McLaughlin Professor and Chair, Department of Surgery, University of Toronto
The team is now in the final stages of a large animal trial and, with interest mounting, they’re hoping to move to a human clinical trial within the next couple of years. Dr. Erwin is a chiropractic researcher on the edge of life-changing discoveries for millions of Canadians living with degenerative disc disease, osteoarthritis and other spinal diseases.